Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001510866 | SCV001718014 | benign | Primary pulmonary hypertension | 2021-09-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000866121 | SCV002048045 | benign | not provided | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501256 | SCV002805120 | likely benign | Pulmonary hypertension, primary, 1; Pulmonary venoocclusive disease 1 | 2022-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169125 | SCV003896538 | likely benign | Inborn genetic diseases | 2023-01-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |